[1]
A. Jonathan, R. Wisaksana, and N. Agustanti, “Decreased in Liver Fibrosis in Patients with HCV/HIV Coinfection After Treatment with Sofosbuvir/Daclatasvir”, InaJGHE, vol. 20, no. 2, pp. 87–95, July 2020.